Germany
Japan
United Kingdom
China
Research Areas
Download
IL2 mouse monoclonal antibody,clone OTI2C9
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
MME mouse monoclonal antibody,clone OTI1E4
| Applications | FC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
USD 420.00
4 Weeks
USD 420.00
4 Weeks
CSF3 mouse monoclonal antibody,clone OTI1A9
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI3F12
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
USD 420.00
4 Weeks
USD 420.00
4 Weeks
CSF3 mouse monoclonal antibody,clone OTI1G6
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI3C10
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
USD 420.00
4 Weeks
USD 420.00
4 Weeks
IL2 mouse monoclonal antibody,clone OTI5A9
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: “NEURO15".
CSF3 mouse monoclonal antibody,clone OTI3A3
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
CSF3 mouse monoclonal antibody,clone OTI1C7
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
Active filters
Category
- Antibodies
Antibody Hosts
- Mouse
Filter by
Target Symbol
- IL6 (130)
- CD4 (120)
- PECAM1 (109)
- IL1RL1 (102)
- PTPRC (88)
- CD99 (84)
- PDCD1 (84)
- CD19 (77)
- LGALS3 (77)
- KIT (71)
- CD68 (70)
- CD5 (65)
- MS4A1 (63)
- CD34 (61)
- NCAM1 (59)
- TNFRSF8 (51)
- CR2 (45)
- WNT3 (45)
- CD2 (39)
- MME (38)
- ESR1 (37)
- FCER2 (36)
- TYRO3 (36)
- CD22 (35)
- CRP (35)
- DVL2 (35)
- IL1RN (35)
- MAPK8 (34)
- CD274 (33)
- ANAPC11 (31)
- CD8A (31)
- ANAPC2 (30)
- ROR2 (30)
- CD33 (29)
- CD14 (28)
- CD79B (28)
- IL2RA (26)
- MAPK9 (26)
- CSF3 (23)
- IL3RA (22)
- ANPEP (19)
- TNF (19)
- CD3E (18)
- FCGR1A (15)
- MAPK10 (15)
- PTK7 (15)
- RORA (15)
- POSTN (14)
- CD74 (12)
- ITGB3 (12)
- CD79A (11)
- IL2 (11)
- IL6R (11)
- CD7 (10)
- IL36G (10)
- AGTPBP1 (9)
- IL12B (8)
- IL1A (8)
- IL6ST (8)
- ROR1 (8)
- FCGR3A (7)
- TLR8 (7)
- CD1A (5)
- ESR2 (5)
- HLA-DRB5 (5)
- ITGA2B (5)
- LEF1 (5)
- TOLLIP (5)
- CALR (4)
- CD163 (4)
- IL1B (4)
- IL36A (4)
- CRYGD (3)
- CXCL8 (3)
- HLA-A (3)
- IL6RA (3)
- WNT3A (3)
- CD46 (2)
- FUT4 (2)
- HLA-DQA2 (2)
- HLA-G (2)
- IL18 (2)
- ITGAX (2)
- TLR3 (2)
- TMED1 (2)
- ANAPC5 (1)
- ARAF (1)
- BRAF (1)
- CASP1 (1)
- CD10 (1)
- CD207 (1)
- CD30 (1)
- CDC42SE2 (1)
- CKMT2 (1)
- ELK3 (1)
- HLA CLASS II (1)
- IL10 (1)
- IL1R1 (1)
- IL1R2 (1)
- IRS1 (1)
Reactivities
Applications
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (2194)
- Transmembrane (1734)
- ES Cell Differentiation/IPS (802)
- Secreted Protein (614)
- Adult stem cells (310)
- Protein Kinase (250)
- Embryonic stem cells (157)
- Stem cell - Pluripotency (118)
- Induced pluripotent stem cells (116)
- Phosphatase (87)
- Transcription Factors (84)
- Cancer stem cells (63)
- Protease (63)
- Nuclear Hormone Receptor (56)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
Pathways
- Hematopoietic cell lineage (1024)
- Cell adhesion molecules (CAMs) (740)
- T cell receptor signaling pathway (389)
- Cytokine-cytokine receptor interaction (383)
- Pathways in cancer (374)
- Primary immunodeficiency (330)
- Toll-like receptor signaling pathway (286)
- Jak-STAT signaling pathway (235)
- NOD-like receptor signaling pathway (230)
- Prion diseases (199)
- Leukocyte transendothelial migration (196)
- B cell receptor signaling pathway (194)
- Graft-versus-host disease (179)
- Antigen processing and presentation (170)
- Wnt signaling pathway (166)
- Melanogenesis (160)
- Hypertrophic cardiomyopathy (HCM) (159)
- Progesterone-mediated oocyte maturation (142)
- MAPK signaling pathway (141)
- Cytosolic DNA-sensing pathway (135)
- Colorectal cancer (119)
- Fc gamma R-mediated phagocytosis (110)
- RIG-I-like receptor signaling pathway (105)
- Endocytosis (99)
- Fc epsilon RI signaling pathway (97)
- Focal adhesion (96)
- Adipocytokine signaling pathway (94)
- Type II diabetes mellitus (94)
- Basal cell carcinoma (89)
- ErbB signaling pathway (85)
- Neurotrophin signaling pathway (83)
- Insulin signaling pathway (82)
- Acute myeloid leukemia (81)
- Epithelial cell signaling in Helicobacter pylori infection (81)
- GnRH signaling pathway (80)
- Pancreatic cancer (79)
- Lysosome (69)
- Oocyte meiosis (63)
- Cell cycle (62)
- Ubiquitin mediated proteolysis (62)
- Type I diabetes mellitus (58)
- Alzheimer's disease (55)
- Renin-angiotensin system (53)
- Regulation of actin cytoskeleton (52)
- Apoptosis (51)
- Hedgehog signaling pathway (49)
- Allograft rejection (47)
- Complement and coagulation cascades (46)
- Systemic lupus erythematosus (45)
- Notch signaling pathway (35)
- Natural killer cell mediated cytotoxicity (33)
- Pathogenic Escherichia coli infection (32)
- Dilated cardiomyopathy (30)
- Asthma (24)
- Autoimmune thyroid disease (23)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (19)
- Metabolic pathways (19)
- Amyotrophic lateral sclerosis (ALS) (18)
- Glutathione metabolism (18)
- TGF-beta signaling pathway (17)
- ECM-receptor interaction (13)
- Viral myocarditis (13)
- Chemokine signaling pathway (10)
- Endometrial cancer (10)
- Prostate cancer (10)
- Adherens junction (8)
- Thyroid cancer (7)
- Bladder cancer (6)
- Chronic myeloid leukemia (6)
- Glioma (6)
- Renal cell carcinoma (6)
- Non-small cell lung cancer (5)
- VEGF signaling pathway (5)
- Vascular smooth muscle contraction (5)
- Long-term potentiation (4)
- Melanoma (4)
- mTOR signaling pathway (4)
- Axon guidance (3)
- Gap junction (3)
- Long-term depression (3)
- Small cell lung cancer (3)
- Tight junction (3)
- Arginine and proline metabolism (1)
- Dorso-ventral axis formation (1)
- Inositol phosphate metabolism (1)
- Phosphatidylinositol signaling system (1)
- Vibrio cholerae infection (1)